Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential Thrombocythemia”

331 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 331 results

Not applicableLooking for participantsNCT07203768
What this trial is testing

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

Who this might be right for
Polycythemia VeraThrombocythemia
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 678
Testing effectiveness (Phase 2)Looking for participantsNCT04282187
What this trial is testing

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Acute Myeloid LeukemiaEssential ThrombocythemiaMyelodysplastic Syndrome+6 more
University of Washington 25
Testing effectiveness (Phase 2)Study completedNCT05223920
What this trial is testing

An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)

Who this might be right for
Thrombocythemia, EssentialPrimary Myelofibrosis
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 81
Large-scale testing (Phase 3)Looking for participantsNCT06456346
What this trial is testing

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Who this might be right for
Essential Thrombocythemia
Merck Sharp & Dohme LLC 300
Early research (Phase 1)Study completedNCT01317875
What this trial is testing

Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)

Who this might be right for
Myelofibrosis
Incyte Corporation 69
Early research (Phase 1)Looking for participantsNCT05714072
What this trial is testing

Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

Who this might be right for
Myelofibrosis Due to and Following Polycythemia Vera
Memorial Sloan Kettering Cancer Center 18
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Not applicableLooking for participantsNCT04645199
What this trial is testing

National Longitudinal Cohort of Hematological Diseases

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaHemophilia+14 more
Institute of Hematology & Blood Diseases Hospital, China 2,300
Large-scale testing (Phase 3)Study completedNCT00934544
What this trial is testing

Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial

Who this might be right for
Myelofibrosis
Novartis Pharmaceuticals 219
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Testing effectiveness (Phase 2)Study completedNCT00039416
What this trial is testing

Imatinib Mesylate in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myelomonocytic LeukemiaEssential ThrombocythemiaPolycythemia Vera+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT04243122
What this trial is testing

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

Who this might be right for
Myeloproliferative Neoplasm (MPN)Essential Thrombocythemia (ET)JAK2 Mutation+3 more
Ottawa Hospital Research Institute 44
Testing effectiveness (Phase 2)Looking for participantsNCT06552429
What this trial is testing

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

Who this might be right for
Essential Thrombocythemia
Xiamen Amoytop Biotech Co., Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT00586651
What this trial is testing

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Who this might be right for
Polycythemia VeraEssential Thrombocytosis
Cephalon 39
Not applicableLooking for participantsNCT01137643
What this trial is testing

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
UNC Lineberger Comprehensive Cancer Center 15,000
Testing effectiveness (Phase 2)Ended earlyNCT01998828
What this trial is testing

Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
Sierra Oncology LLC - a GSK company 39
Early research (Phase 1)Study completedNCT02407080
What this trial is testing

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
John Mascarenhas 13
Testing effectiveness (Phase 2)UnknownNCT01298934
What this trial is testing

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Who this might be right for
Primary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis
Ronald Hoffman 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT02515630
What this trial is testing

Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)

Who this might be right for
Primary Myelofibrosis (PMF)Post-polycythemia Vera (Post-PV) MyelofibrosisPostessential Thrombocythemia (Post-ET) Myelofibrosis
Sierra Oncology LLC - a GSK company 41
Load More Results